Cargando…
Airway Complications After Lung Transplant for Post Coronaviral Disease (COVID-19) Acute Respiratory Distress Syndrome (ARDS) Related End Stage Lung Disease: Single Centre Experience
PURPOSE: Severe COVID-19 ARDS related end stage lung fibrosis with irreversible changes is a newer indication for lung transplantation with acceptable survival rate. Airway complication post lung transplant is a major source of morbidity and mortality with incidence as high as 25 to 49 percent. Pati...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988571/ http://dx.doi.org/10.1016/j.healun.2022.01.311 |
_version_ | 1784682990810431488 |
---|---|
author | Kumar, S. Shah, U. Ravipati, S. Rahulan, V. Kamath, A. Kumar, P. Panda, S. Kori, S. John, P. Nagaraju, M. Arora, S. Dutta, P. Attawar, S. |
author_facet | Kumar, S. Shah, U. Ravipati, S. Rahulan, V. Kamath, A. Kumar, P. Panda, S. Kori, S. John, P. Nagaraju, M. Arora, S. Dutta, P. Attawar, S. |
author_sort | Kumar, S. |
collection | PubMed |
description | PURPOSE: Severe COVID-19 ARDS related end stage lung fibrosis with irreversible changes is a newer indication for lung transplantation with acceptable survival rate. Airway complication post lung transplant is a major source of morbidity and mortality with incidence as high as 25 to 49 percent. Patients with end stage COVID-19 fibrosis are likely to be clinically deconditioned with long duration of extracorporeal oxygenator (ECMO) support, high burden of sepsis and prolonged respiratory support which may affect the airways post lung transplantation. METHODS: This is a retrospective observational study after obtaining institutional ethical clearance. We reviewed electronic medical data of patients who underwent lung transplantation for post COVID-19 ARDS related fibrosis. We evaluated the incidence and type of airway complications and the various therapeutic interventions applied for its management. RESULTS: Between May 2020 and September 2021 our centre performed 23 bilateral lung transplants for end stage COVID-19 ARDS related fibrosis. 22 patients were on ECMO support with mean duration of 50.9 days before transplantation. All patients underwent lung transplantation with central Veno-Arterial ECMO support with mean organ ischaemia time of 360±154 minutes. The incidence of airway complication in our study group was 56%. We observed anastomotic narrowing in 3(13%), distal airway narrowing in 4(17%) and sloughing/coating of anastomotic site in 5(22%) patients. Nonspecific inflammatory polypi around the bronchial anastomotic site were noticed in 4(17%) and mild airway anastomotic dehiscence in 2 subjects. 8(34%) patients required serial bronchoscopy and balloon dilatation; 2 among them mandated additional cautery usage. 2 cases underwent polypectomy, further 4 subjects needed bronchial stent placement. 5 (21%) recipients were discharged with Tracheostomy while rest were successfully decannulated in the ward. CONCLUSION: We observed a high incidence of airway complications in post lung transplant for COVID-19 ARDS related fibrosis. Early detection, timely management and serial follow up is of paramount importance in this subset of patients. |
format | Online Article Text |
id | pubmed-8988571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89885712022-04-11 Airway Complications After Lung Transplant for Post Coronaviral Disease (COVID-19) Acute Respiratory Distress Syndrome (ARDS) Related End Stage Lung Disease: Single Centre Experience Kumar, S. Shah, U. Ravipati, S. Rahulan, V. Kamath, A. Kumar, P. Panda, S. Kori, S. John, P. Nagaraju, M. Arora, S. Dutta, P. Attawar, S. J Heart Lung Transplant (290) PURPOSE: Severe COVID-19 ARDS related end stage lung fibrosis with irreversible changes is a newer indication for lung transplantation with acceptable survival rate. Airway complication post lung transplant is a major source of morbidity and mortality with incidence as high as 25 to 49 percent. Patients with end stage COVID-19 fibrosis are likely to be clinically deconditioned with long duration of extracorporeal oxygenator (ECMO) support, high burden of sepsis and prolonged respiratory support which may affect the airways post lung transplantation. METHODS: This is a retrospective observational study after obtaining institutional ethical clearance. We reviewed electronic medical data of patients who underwent lung transplantation for post COVID-19 ARDS related fibrosis. We evaluated the incidence and type of airway complications and the various therapeutic interventions applied for its management. RESULTS: Between May 2020 and September 2021 our centre performed 23 bilateral lung transplants for end stage COVID-19 ARDS related fibrosis. 22 patients were on ECMO support with mean duration of 50.9 days before transplantation. All patients underwent lung transplantation with central Veno-Arterial ECMO support with mean organ ischaemia time of 360±154 minutes. The incidence of airway complication in our study group was 56%. We observed anastomotic narrowing in 3(13%), distal airway narrowing in 4(17%) and sloughing/coating of anastomotic site in 5(22%) patients. Nonspecific inflammatory polypi around the bronchial anastomotic site were noticed in 4(17%) and mild airway anastomotic dehiscence in 2 subjects. 8(34%) patients required serial bronchoscopy and balloon dilatation; 2 among them mandated additional cautery usage. 2 cases underwent polypectomy, further 4 subjects needed bronchial stent placement. 5 (21%) recipients were discharged with Tracheostomy while rest were successfully decannulated in the ward. CONCLUSION: We observed a high incidence of airway complications in post lung transplant for COVID-19 ARDS related fibrosis. Early detection, timely management and serial follow up is of paramount importance in this subset of patients. Published by Elsevier Inc. 2022-04 2022-04-07 /pmc/articles/PMC8988571/ http://dx.doi.org/10.1016/j.healun.2022.01.311 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | (290) Kumar, S. Shah, U. Ravipati, S. Rahulan, V. Kamath, A. Kumar, P. Panda, S. Kori, S. John, P. Nagaraju, M. Arora, S. Dutta, P. Attawar, S. Airway Complications After Lung Transplant for Post Coronaviral Disease (COVID-19) Acute Respiratory Distress Syndrome (ARDS) Related End Stage Lung Disease: Single Centre Experience |
title | Airway Complications After Lung Transplant for Post Coronaviral Disease (COVID-19) Acute Respiratory Distress Syndrome (ARDS) Related End Stage Lung Disease: Single Centre Experience |
title_full | Airway Complications After Lung Transplant for Post Coronaviral Disease (COVID-19) Acute Respiratory Distress Syndrome (ARDS) Related End Stage Lung Disease: Single Centre Experience |
title_fullStr | Airway Complications After Lung Transplant for Post Coronaviral Disease (COVID-19) Acute Respiratory Distress Syndrome (ARDS) Related End Stage Lung Disease: Single Centre Experience |
title_full_unstemmed | Airway Complications After Lung Transplant for Post Coronaviral Disease (COVID-19) Acute Respiratory Distress Syndrome (ARDS) Related End Stage Lung Disease: Single Centre Experience |
title_short | Airway Complications After Lung Transplant for Post Coronaviral Disease (COVID-19) Acute Respiratory Distress Syndrome (ARDS) Related End Stage Lung Disease: Single Centre Experience |
title_sort | airway complications after lung transplant for post coronaviral disease (covid-19) acute respiratory distress syndrome (ards) related end stage lung disease: single centre experience |
topic | (290) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988571/ http://dx.doi.org/10.1016/j.healun.2022.01.311 |
work_keys_str_mv | AT kumars airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT shahu airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT ravipatis airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT rahulanv airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT kamatha airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT kumarp airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT pandas airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT koris airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT johnp airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT nagarajum airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT aroras airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT duttap airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience AT attawars airwaycomplicationsafterlungtransplantforpostcoronaviraldiseasecovid19acuterespiratorydistresssyndromeardsrelatedendstagelungdiseasesinglecentreexperience |